GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹14 Cr | ₹18 Cr | ₹9.42 Cr | ₹11 Cr | ₹7.66 Cr |
What is the latest Sundry Debtors ratio of GENNEX LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹9.42 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹7.66 Cr |
How is Sundry Debtors of GENNEX LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | -20.49 | |
| Mar2024 | ₹18 Cr | 89.14 | |
| Mar2023 | ₹9.42 Cr | -16.76 | |
| Mar2022 | ₹11 Cr | 47.75 | |
| Mar2021 | ₹7.66 Cr | - | |
Compare Sundry Debtors of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹258.0 Cr | -5.6% | 5.6% | -21.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,933.0 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,549.0 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,652.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -5.6% |
5.6% |
-21.7% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses